Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

NCT05676450 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

517

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DIAGNOSTIC_TEST: cell-free DNA

Sponsor

M.D. Anderson Cancer Center